Featured Research

from universities, journals, and other organizations

Physicists push new Parkinson's treatment toward clinical trials

Date:
April 21, 2014
Source:
Michigan State University
Summary:
The most effective way to tackle debilitating diseases is to punch them at the start and keep them from growing. Research shows that a small 'molecular tweezer' keeps proteins from clumping, or aggregating, the first step of neurological disorders such as Parkinson's disease, Alzheimer's disease and Huntington's disease.

The most effective way to tackle debilitating diseases is to punch them at the start and keep them from growing.

Related Articles


Research at Michigan State University, published in the Journal of Biological Chemistry, shows that a small "molecular tweezer" keeps proteins from clumping, or aggregating, the first step of neurological disorders such as Parkinson's disease, Alzheimer's disease and Huntington's disease.

The results are pushing the promising molecule toward clinical trials and actually becoming a new drug, said Lisa Lapidus, MSU associate professor of physics and astronomy and co-author of the paper.

"By the time patients show symptoms and go to a doctor, aggregation already has a stronghold in their brains," she said. "In the lab, however, we can see the first steps, at the very place where the drugs could be the most effective. This could be a strong model for fighting Parkinson's and other diseases that involve neurotoxic aggregation."

Lapidus' lab uses lasers to study the speed of protein reconfiguration before aggregation, a technique Lapidus pioneered. Proteins are chains of amino acids that do most of the work in cells. Scientists understand protein structure, but they don't know how they are built -- a process known as folding.

Lapidus' lab has shed light on the process by correlating the speed at which an unfolded protein changes shape, or reconfigures, with its tendency to clump or bind with other proteins. If reconfiguration is much faster or slower than the speed at which proteins bump into each other, aggregation is slow, but if reconfiguration is the same speed, aggregation is fast.

Srabasti Acharya, lead author and doctoral candidate in Lapidus' lab, tested the molecule, CLR01, which was patented jointly by researchers at the University of Duisburg-Essen (Germany) and UCLA. CLR01 binds to the protein and prevents aggregation by speeding up reconfiguration. It's like a claw that attaches to the amino acid lysine, which is part of the protein.

This work was preceded by Lapidus' research involving the spice curcumin. While the spice molecules put the researchers on a solid path, the molecules weren't viable drug candidates because they cannot cross the blood-brain barrier, or BBB, the filter that controls what chemicals reach the brain.

It's the BBB, in fact, that disproves the notion that people should simply eat more spicy food to stave off Parkinson's disease.

Spicy misconceptions notwithstanding, CLR01 mimics curcumin molecules' ability to prevent aggregation. But unlike the spice, CLR01 can crossover the BBB and treat its targeted site. Not only do they go to the right place, but CLR01 molecules also work even better because they speed up reconfiguration even more than curcumin. Additionally Acharya showed that CLR01 slows the first step of aggregation, and the results from the study map out a clear road map for moving the drug to clinical trials.

Hearing about a nontraditional physics lab that was advancing medicine is what brought Acharya to work with Lapidus.

"I knew I wanted to study physics when I came to MSU, but when I heard Dr. Lapidus' presentation during orientation, I knew this is what I wanted to do," Acharya said. "We are using physics to better understand biology to help cure actual diseases."


Story Source:

The above story is based on materials provided by Michigan State University. Note: Materials may be edited for content and length.


Journal Reference:

  1. S. Acharya, B. M. Safaie, P. Wongkongkathep, M. I. Ivanova, A. Attar, F.-G. Klarner, T. Schrader, J. A. Loo, G. Bitan, L. J. Lapidus. Molecular Basis for Preventing  -Synuclein Aggregation by a Molecular Tweezer. Journal of Biological Chemistry, 2014; 289 (15): 10727 DOI: 10.1074/jbc.M113.524520

Cite This Page:

Michigan State University. "Physicists push new Parkinson's treatment toward clinical trials." ScienceDaily. ScienceDaily, 21 April 2014. <www.sciencedaily.com/releases/2014/04/140421135918.htm>.
Michigan State University. (2014, April 21). Physicists push new Parkinson's treatment toward clinical trials. ScienceDaily. Retrieved April 1, 2015 from www.sciencedaily.com/releases/2014/04/140421135918.htm
Michigan State University. "Physicists push new Parkinson's treatment toward clinical trials." ScienceDaily. www.sciencedaily.com/releases/2014/04/140421135918.htm (accessed April 1, 2015).

Share This


More From ScienceDaily



More Matter & Energy News

Wednesday, April 1, 2015

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

7-Year-Old Girl Gets 3-D Printed 'robohand'

7-Year-Old Girl Gets 3-D Printed 'robohand'

AP (Mar. 31, 2015) — Although she never had much interest in prosthetic limbs before, Faith Lennox couldn&apos;t wait to slip on her new robohand. The 7-year-old, who lost part of her left arm when she was a baby, grabbed it as soon as it came off a 3-D printer. (March 31) Video provided by AP
Powered by NewsLook.com
Dutch Architects Show Off 3D House-Building Prowess

Dutch Architects Show Off 3D House-Building Prowess

Reuters - Innovations Video Online (Mar. 31, 2015) — Dutch architects are constructing a 3D-printed canal-side home, which they hope will spark an environmental revolution in the house-building industry. Jim Drury reports. Video provided by Reuters
Powered by NewsLook.com
Solar Plane Stops in China

Solar Plane Stops in China

Reuters - News Video Online (Mar. 31, 2015) — Solar Impulse 2 stops over in China&apos;s Chonqing, completing the fifth leg in its bid to become the first solar powered plane to travel around the globe. Rough Cut (no reporter narration). Video provided by Reuters
Powered by NewsLook.com
Solar Impulse Lands in China After 20-Hour Flight from Myanmar

Solar Impulse Lands in China After 20-Hour Flight from Myanmar

AFP (Mar. 31, 2015) — Solar Impulse 2 lands in China, the world&apos;s biggest carbon emitter, completing the fifth leg of its landmark global circumnavigation powered solely by the sun. Duration: 00:55 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Space & Time

Matter & Energy

Computers & Math

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins